Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 23, 2014 - Issue 12
Submit an article Journal homepage
284
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Phase II drugs currently being investigated for the treatment of hypogonadism

Emeka UdedibiaUniversity Urology, Manhattan Medical Research, 215 Lexington Ave, Floor 20, New York, NY 10016, USA+1 212 686 9015; +1 212 686 8607; [email protected]
, RPA-C &
Jed KaminetskyUniversity Urology, Manhattan Medical Research, 215 Lexington Ave, Floor 20, New York, NY 10016, USA+1 212 686 9015; +1 212 686 8607; [email protected]
, MD
Pages 1605-1618 | Published online: 12 Aug 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Blake Wynia & Jed C Kaminetsky. (2015) Current and emerging testosterone therapies for male hypogonadism. Research and Reports in Endocrine Disorders 5, pages 59-69.
Read now

Articles from other publishers (2)

Katsuji Aikawa, Moriteru Asano, Koji Ono, Noriyuki Habuka, Jason Yano, Keith Wilson, Hisashi Fujita, Hitoshi Kandori, Takahito Hara, Megumi Morimoto, Takashi Santou, Masuo Yamaoka, Masaharu Nakayama & Atsushi Hasuoka. (2017) Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate. Bioorganic & Medicinal Chemistry 25:13, pages 3330-3349.
Crossref
Moriteru Asano, Takenori Hitaka, Takashi Imada, Masami Yamada, Megumi Morimoto, Hiromi Shinohara, Takahito Hara, Masuo Yamaoka, Takashi Santou, Masaharu Nakayama, Yumi Imai, Noriyuki Habuka, Jason Yano, Keith Wilson, Hisashi Fujita & Atsushi Hasuoka. (2017) Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives. Bioorganic & Medicinal Chemistry Letters 27:9, pages 1897-1901.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.